Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia

Ther Adv Respir Dis. Jan-Dec 2020;14:1753466620951043. doi: 10.1177/1753466620951043.

Abstract

The reviews of this paper are available via the supplemental material section.

Keywords: COVID-19; intensive care; invasive mechanical ventilation; surfactant; viral pneumonia.

Publication types

  • Letter

MeSH terms

  • Aged
  • COVID-19
  • Combined Modality Therapy
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / therapy*
  • Critical Care / methods
  • Follow-Up Studies
  • Humans
  • Instillation, Drug
  • Intensive Care Units
  • Italy
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / therapy*
  • Respiration, Artificial / methods*
  • Respiratory Function Tests
  • Retrospective Studies
  • Risk Assessment
  • Sampling Studies
  • Severe Acute Respiratory Syndrome / diagnosis
  • Severe Acute Respiratory Syndrome / therapy*
  • Surface-Active Agents / administration & dosage*
  • Treatment Outcome

Substances

  • Surface-Active Agents